Interestingly, a reduced plasma gelsolin level was also recognized as a potential biomarker in precancerous conditions such as inflammation, sepsis, and HIV through releasing of inflammatory mediators, which suggests the clinical usefulness of recombinant gelsolin [39,40]. The gene discussed is GSN; the disease is Sepsis.